BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 14568570)

  • 1. Silymarin is a selective estrogen receptor beta (ERbeta) agonist and has estrogenic effects in the metaphysis of the femur but no or antiestrogenic effects in the uterus of ovariectomized (ovx) rats.
    Seidlová-Wuttke D; Becker T; Christoffel V; Jarry H; Wuttke W
    J Steroid Biochem Mol Biol; 2003 Aug; 86(2):179-88. PubMed ID: 14568570
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence for selective estrogen receptor modulator activity in a black cohosh (Cimicifuga racemosa) extract: comparison with estradiol-17beta.
    Seidlova-Wuttke D; Hesse O; Jarry H; Christoffel V; Spengler B; Becker T; Wuttke W
    Eur J Endocrinol; 2003 Oct; 149(4):351-62. PubMed ID: 14514351
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidences for antiosteoporotic and selective estrogen receptor modulator activity of silymarin compared with ethinylestradiol in ovariectomized rats.
    El-Shitany NA; Hegazy S; El-Desoky K
    Phytomedicine; 2010 Feb; 17(2):116-25. PubMed ID: 19577454
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of estrogen receptor alpha- and beta-selective substances in the metaphysis of the tibia and on serum parameters of bone and fat tissue metabolism of ovariectomized rats.
    Seidlová-Wuttke D; Prelle K; Fritzemeier KH; Wuttke W
    Bone; 2008 Nov; 43(5):849-55. PubMed ID: 18708178
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of SERM (selective estrogen receptor modulator) treatment on growth and proliferation in the rat uterus.
    Stygar D; Muravitskaya N; Eriksson B; Eriksson H; Sahlin L
    Reprod Biol Endocrinol; 2003 May; 1():40. PubMed ID: 12777179
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of estradiol benzoate, raloxifen and an ethanolic extract of Cimicifuga racemosa in nonclassical estrogen regulated organs of ovariectomized rats.
    Seidlova-Wuttke D; Jarry H; Wuttke W
    Planta Med; 2009 Oct; 75(12):1279-85. PubMed ID: 19350480
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combinatorial effects of the phytoestrogen genistein and of estradiol in uterus and liver of female Wistar rats.
    Diel P; Hertrampf T; Seibel J; Laudenbach-Leschowsky U; Kolba S; Vollmer G
    J Steroid Biochem Mol Biol; 2006 Dec; 102(1-5):60-70. PubMed ID: 17049845
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tissue- and hormone-dependent progesterone receptor distribution in the rat uterus.
    Sahlin L; Masironi B; Akerberg S; Eriksson H
    Reprod Biol Endocrinol; 2006 Sep; 4():47. PubMed ID: 16965620
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential regulation of estrogen receptor alpha and beta mRNAs in the rat uterus during pregnancy and labor: possible involvement of estrogen receptors in oxytocin receptor regulation.
    Murata T; Narita K; Honda K; Matsukawa S; Higuchi T
    Endocr J; 2003 Oct; 50(5):579-87. PubMed ID: 14614214
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fructus Ligustri Lucidi modulates estrogen receptor expression with no uterotrophic effect in ovariectomized rats.
    Tang YQ; Li C; Sun XJ; Liu Y; Wang XT; Guo YB; Wang LL; Ma RF; Niu JZ; Fu M; Zhang DW; Li Y
    BMC Complement Altern Med; 2018 Apr; 18(1):118. PubMed ID: 29609586
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential regulation of dehydroepiandrosterone and estrogen on bone and uterus in ovariectomized mice.
    Wang L; Wang YD; Wang WJ; Li DJ
    Osteoporos Int; 2009 Jan; 20(1):79-92. PubMed ID: 18690485
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estrogen supplementation modulates effects of the endocrine disrupting pollutant PCB126 in rat bone and uterus: diverging effects in ovariectomized and intact animals.
    Lind PM; Eriksen EF; Lind L; Orberg J; Sahlin L
    Toxicology; 2004 Jul; 199(2-3):129-36. PubMed ID: 15147787
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of ovarian hormone treatment on the gene expression of muscarinic acetylcholine receptors in the ovariectomized rat myometrium.
    Yasuda K; Sumi G; Kanamori C; Nakajima T; Tsuzuki T; Cho H; Nishigaki A; Okada H; Kanzaki H
    J Steroid Biochem Mol Biol; 2014 Sep; 143():81-9. PubMed ID: 24583025
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel ligands balance estrogen receptor β and α agonism for safe and effective suppression of the vasomotor response in the ovariectomized female rat model of menopause.
    McGregor C; Sau A; Ruddy SC; Leung D; Webb M; Durst T; Wright JS; Lagace D; Pratt MA
    Endocrinology; 2014 Jul; 155(7):2480-91. PubMed ID: 24823389
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of genistein as a selective estrogen receptor beta agonist on the expression of Calbindin-D9k in the uterus of immature rats.
    Lee GS; Choi KC; Kim HJ; Jeung EB
    Toxicol Sci; 2004 Dec; 82(2):451-7. PubMed ID: 15456916
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pure estrogenic effect of benzophenone-2 (BP2) but not of bisphenol A (BPA) and dibutylphtalate (DBP) in uterus, vagina and bone.
    Seidlová-Wuttke D; Jarry H; Wuttke W
    Toxicology; 2004 Dec; 205(1-2):103-12. PubMed ID: 15458795
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dissecting physiological roles of estrogen receptor alpha and beta with potent selective ligands from structure-based design.
    Hillisch A; Peters O; Kosemund D; Müller G; Walter A; Schneider B; Reddersen G; Elger W; Fritzemeier KH
    Mol Endocrinol; 2004 Jul; 18(7):1599-609. PubMed ID: 15105439
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of estrogen receptor (ER) isoform messenger RNA expression by different ER ligands in female rat pituitary.
    Tena-Sempere M; Navarro VM; Mayen A; Bellido C; Sánchez-Criado JE
    Biol Reprod; 2004 Mar; 70(3):671-8. PubMed ID: 14613904
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential spatiotemporal regulation of lactoferrin and progesterone receptor genes in the mouse uterus by primary estrogen, catechol estrogen, and xenoestrogen.
    Das SK; Tan J; Johnson DC; Dey SK
    Endocrinology; 1998 Jun; 139(6):2905-15. PubMed ID: 9607801
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TAS-108, a novel oral steroidal antiestrogenic agent, is a pure antagonist on estrogen receptor alpha and a partial agonist on estrogen receptor beta with low uterotrophic effect.
    Yamamoto Y; Shibata J; Yonekura K; Sato K; Hashimoto A; Aoyagi Y; Wierzba K; Yano S; Asao T; Buzdar AU; Terada T
    Clin Cancer Res; 2005 Jan; 11(1):315-22. PubMed ID: 15671561
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.